awards grant
- AAV-Based Gene Therapy for the Long-Term Treatment of CLN2-Associated Retinal Degeneration and Prevention of Blindness in CLN2 Patients
- Developing a novel cell therapy to treat Type 1 diabetes
- Development of Selective Small Molecule AR-V7 Inhibitors for Prostate Cancer Treatment
- Development of cGAS Inhibitors to Treat Neurodegenerative Diseases
- Immunologic Eradication of Myeloproliferative Neoplasm Stem Cells